Collins applauds advancement of 25 bills addressing the opioid epidemic
Press Release, Congressman Chris Collins
WASHINGTON, DC – Congressman Chris Collins (NY-27), member of the Energy and Commerce Committee, applauded Wedneday’s advancement of 25 bills out of the Committee to help combat the opioid crisis. Collins championed three of these pieces of legislation that will head to the House floor.
“The opioid epidemic is impacting every community across America and we have to take action in order to save lives,” said Collins. “We have seen far too many innocent lives lost and families torn apart because of addiction. I’m hopeful that this package of bills will help individuals get the treatment they need and give communities the resources required to stop this epidemic in its tracks.”
Collins joined fellow New Yorker, Congressman Hakeem Jeffries, in introducing the Synthetic Drug Awareness Act of 2017 that would require the Surgeon General to report to Congress the public health effects of the rise of synthetic drug use by 12- to 18-year-olds. Currently, Congress does not have sufficient information to craft the unique types of public health and law enforcement approaches that could save our nation’s children from these dangerous substances.
Collins also introduced the Eliminating Opioid Related Infectious Diseases Act of 2018 with Congressman Leonard Lance, Congressman Joseph Kennedy, Congresswoman Anna Eshoo, Congressman Joe Barton, and Congresswoman Doris Matsui that focuses specifically on how the opioid epidemic has contributed to an increase in infectious diseases like Hepatitis C and HIV/AIDS. Increased monitoring and education will lead to a better understanding of the impacts that this crisis is having on public health.
Finally, Collins introduced legislation with Congressman Eric Paulson, Congressman Ron Kind, and Congressman Connor Lamb that would require Medicare to send an annual notice to Part D patients about the adverse effects associated with prolonged opioid use. By improving awareness and education, the Medicare Clear Health Options in Care for Enrollees (CHOICE) Act will help patients be more inclined to watch for the warning signs of addiction and be more informed to talk with their doctors on their options for pain management.
The additional bills focus on helping patients receive treatment and making sure these drugs do not get into the wrong hands. The Committee has identified issues with enforcement, prevention, and coverage within Medicare, and the additional legislation provides solutions that will address these areas.
A background memo, electronic copies of the legislation, and live stream of the markup can be found by clicking here. The Committee plans to hold a second markup on opioid legislation on May 17.
